1
|
Chrobak AA, Rusinek J, Dec-Ćwiek M, Porębska K, Siwek M. Content overlap of 91 dystonia symptoms among the seven most commonly used cervical dystonia scales. Neurol Sci 2024; 45:1507-1514. [PMID: 37910323 PMCID: PMC10943139 DOI: 10.1007/s10072-023-07157-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2023] [Accepted: 10/19/2023] [Indexed: 11/03/2023]
Abstract
INTRODUCTION Dystonia is a movement disorder characterized by sustained or intermittent muscle contractions. Cervical dystonia (CD) is the most common focal dystonia. There are several instruments assessing the symptoms of CD. However, different scales assess different features which may lead to poor patient evaluation. AIM The aim of the study was to evaluate the degree of overlap of most often used CD rating scales identified by the literature review. METHODS A thorough search of the Medline database was conducted in September 2021. Then the frequency of each scale was calculated, and 7 most common scales were included in the content overlap analysis using Jaccard index (0 - no overlap, 1 - full overlap). RESULTS Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS), Tsui score, Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS), Cervical Dystonia Impact Profile 58 (CDIP-58), Craniocervical Dystonia Questionnaire 24 (CDQ-24), Cervical Dystonia Severity Rating Scale (CDSS), Cervical Dystonia Severity Rating Scale (DDS) and The Dystonia Non-Motor Symptoms Questionnaire (DNMSQuest) were the most common scales. 91 CD symptoms were distinguished from 134 items used in the scales. The mean overlap among all scales was 0.17. 52 (62%) symptoms were examined by more than one scale. The CIDP-58 captured the highest number of symptoms (63.0%), while the CDSS captured the lowest number (8.0%). None of the symptoms were examined by seven instruments. CONCLUSIONS There was a very weak overlap among scales. High inconsistency between the scales may lead to highly different dystonia severity assessment in clinical practice. Thus, the instruments should be combined.
Collapse
Affiliation(s)
- Adrian Andrzej Chrobak
- Department of Adult Psychiatry, Chair of Psychiatry, Jagiellonian University Medical College, Kraków, Poland
| | - Jakub Rusinek
- Students' Scientific Group of Neurology at the Department of Neurology, Jagiellonian University Medical College, Kraków, Poland
| | - Małgorzata Dec-Ćwiek
- Department of Neurology, Jagiellonian University Medical College, Kraków, Poland
| | - Karolina Porębska
- Department of Neurology, Jagiellonian University Medical College, Kraków, Poland
| | - Marcin Siwek
- Department of Affective Disorders, Chair of Psychiatry, Jagiellonian University Medical College, Kopernika 21a St., 31-501, Kraków, Poland.
| |
Collapse
|
2
|
Rusinek J, Porębska K, Sawczyńska K, Witkowska M, Dec-Ćwiek M. Visual disturbances in patients with Parkinson's Disease treated with oral medications or deep brain stimulation. Neurol Neurochir Pol 2023; 57:392-396. [PMID: 37501541 DOI: 10.5603/pjnns.a2023.0048] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2023] [Revised: 06/13/2023] [Accepted: 07/12/2023] [Indexed: 07/29/2023]
Abstract
AIM OF THE STUDY Ophthalmological symptoms are common in patients with Parkinson's Disease (PD) and can be evaluated by the Visual Impairment in Parkinson's Disease Questionnaire (VIPD-Q). This study aimed to assess the prevalence of ophthalmological symptoms in PD depending on the type of treatment used i.e. pharmacological or subthalamic nucleus deep brain stimulation (STN-DBS). MATERIAL AND METHODS We performed a cross-sectional study. The data was gathered from a VIPD-Q and from medical records. Patients with PD were divided into two groups based on the type of treatment - pharmacological (control group, CG) (39 patients) or STN-DBS (40 patients). RESULTS The great majority of patients - 72 (91.1%) - experienced an ophthalmological symptom. The prevalence of three symptoms differed significantly between the groups. A burning sensation or a gritty feeling in the eyes occurred more often in patients in the STN-DBS group (40.0% vs. 15.4%; p = 0.015). On the other hand, the inability to read plain text on a coloured or grey background and problems with rapid changes of light intensity were more common in the CG group (38.5% vs. 15.0%, p = 0.018 and 28.2% vs. 10.0%, p = 0.039, respectively). CONCLUSIONS AND CLINICAL IMPLICATIONS The prevalence of ophthalmological symptoms in PD is high. Despite significant differences in the three symptoms, the overall prevalence of ophthalmological clinical features was similar in the evaluated groups.
Collapse
Affiliation(s)
- Jakub Rusinek
- Students' Scientific Group of Neurology, Department of Neurology, Jagiellonian University Medical College, Krakow, Poland.
| | - Karolina Porębska
- Department of Neurology, Jagiellonian University Medical College, Krakow, Poland
| | - Katarzyna Sawczyńska
- Department of Neurology, Jagiellonian University Medical College, Krakow, Poland
| | - Magdalena Witkowska
- Department of Neurology, Jagiellonian University Medical College, Krakow, Poland
| | - Małgorzata Dec-Ćwiek
- Department of Neurology, Jagiellonian University Medical College, Krakow, Poland
| |
Collapse
|
3
|
Dec-Ćwiek M, Sawczyńska K, Porębska K, Kubala M, Witkowska M, Żmijewska K. KinesioTaping: impact on non-motor symptoms in cervical dystonia patients treated with botulinum toxin injection. Neurol Neurochir Pol 2023; 58:127-133. [PMID: 37376975 DOI: 10.5603/pjnns.a2023.0042] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2023] [Revised: 05/10/2023] [Accepted: 06/05/2023] [Indexed: 06/29/2023]
Abstract
AIM OF THE STUDY To assess whether combined therapy with botulinum toxin injections (BoNT) and KinesioTaping could be helpful in managing non-motor symptoms (NMS) of cervical dystonia (CD). MATERIAL AND METHODS Seventeen patients with CD were enrolled in this single-centre, prospective, evaluator-blinded, randomised, crossover trial. We compared three forms of treatment: BoNT treatment alone, or combined with KinesioTaping, or combined with ShamTaping. NMS were assessed using the 14-item self-reported questionnaire proposed by Klingelhoefer, the Hospital Anxiety and Depression Scale (HADS) and the Pittsburgh Sleep Quality Index (PSQI). RESULTS There were no significant differences between the groups concerning mean results of HADS and PSQI scales, or mean total number of NMS after the procedures. The mean change from baseline HADS and PSQI scores, and total number of NMS after the procedure, also did not differ significantly between groups. ShamTaping combined with BoNT significantly increased the prevalence of pain. CONCLUSIONS AND CLINICAL IMPLICATIONS Our study did not confirm the effectiveness of combined therapy of BoNT and KinesioTaping in the management of NMS in patients with CD. Due to a potential negative effect of improper taping on pain in CD, patients with CD should only experience KinesioTaping as an adjunctive therapy, and if it is performed by a trained, experienced physiotherapist.
Collapse
Affiliation(s)
- Małgorzata Dec-Ćwiek
- Department of Neurology, Jagiellonian University, Medical College, Krakow, Poland.
| | - Katarzyna Sawczyńska
- Department of Neurology, Jagiellonian University, Medical College, Krakow, Poland
| | - Karolina Porębska
- Department of Neurology, Jagiellonian University, Medical College, Krakow, Poland
| | - Marcin Kubala
- Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Krakow University, Krakow, Poland
| | - Magdalena Witkowska
- Department of Neurology, Jagiellonian University, Medical College, Krakow, Poland
| | - Kinga Żmijewska
- Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Krakow University, Krakow, Poland
- Department of Orthopaedics and Physiotherapy, Jagiellonian University, Medical College, Krakow, Poland
| |
Collapse
|
4
|
Wójcik K, Franciszek Kołek M, Dec-Ćwiek M, Słowik A, Bosak M. Trends in antiseizure medications utilization among women of childbearing age with epilepsy in Poland between 2015 and 2019. Epilepsy Behav 2023; 139:109091. [PMID: 36682232 DOI: 10.1016/j.yebeh.2023.109091] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/18/2022] [Revised: 01/01/2023] [Accepted: 01/05/2023] [Indexed: 01/21/2023]
Abstract
PURPOSE To determine trends in the use of antiseizure medications (ASMs) among women of childbearing age (WOCA) and girls aged 12-14 years with epilepsy between 2015 and 2019 in Poland. METHODS The study used data from the Pex database, which captures information on prescriptions dispensed from 85% of community pharmacies in Poland. The prescriptions issued by neurologists who provide epilepsy care in Poland were studied. Six of the most commonly prescribed ASMs were analyzed: carbamazepine, lamotrigine, levetiracetam, oxcarbazepine, topiramate, and valproate. RESULTS The use of valproate and carbamazepine decreased in all age groups. Among the newer ASMs, the use of lamotrigine, levetiracetam, and topiramate increased and oxcarbazepine decreased significantly in WOCA. The only subgroup with statistically significant changes in all ASMs prescriptions were women aged 19-34 years. For girls aged 12-14 years, significant changes were found only for valproate and carbamazepine. In the last year of observation (2019) valproate and lamotrigine accounted for two-thirds of ASMs units prescribed to WOCA. Valproate accounted for half of the prescribed drug units in girls aged 12-14 years. The lowest rates of VPA prescriptions were found in women aged 19-34 years. CONCLUSIONS There is a change in prescribing habits in WOCA with epilepsy in Poland with trends toward using less teratogenic ASMs. However, many WOCAs are treated with valproate and topiramate despite their known teratogenicity risk. Valproate is still the most commonly prescribed ASM in WOCA and girls aged 12-14 years. Educational interventions for healthcare professionals are needed to improve prescribing practices in WOCA with epilepsy in Poland.
Collapse
Affiliation(s)
| | | | - Małgorzata Dec-Ćwiek
- University Hospital in Kraków, Poland; Jagiellonian University, Faculty of Medicine, Department of Neurology, Poland
| | - Agnieszka Słowik
- University Hospital in Kraków, Poland; Jagiellonian University, Faculty of Medicine, Department of Neurology, Poland
| | - Magdalena Bosak
- University Hospital in Kraków, Poland; Jagiellonian University, Faculty of Medicine, Department of Neurology, Poland.
| |
Collapse
|
5
|
Dec-Ćwiek M, Porębska K, Sawczyńska K, Kubala M, Witkowska M, Zmijewska K, Antczak J, Pera J. KinesioTaping after botulinum toxin type A for cervical dystonia in adult patients. Brain Behav 2022; 12:e2541. [PMID: 35238494 PMCID: PMC9014990 DOI: 10.1002/brb3.2541] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/26/2021] [Revised: 01/08/2022] [Accepted: 02/13/2022] [Indexed: 11/30/2022] Open
Abstract
INTRODUCTION Studies explored physiotherapeutic approaches in cervical dystonia (CD) patients with or without botulinum toxin (BoNT) injections, however the results are varying. There are no clinical trials investigating the effects of kinesiology taping in CD patients. The objective of this study is to investigate the efficacy of kinesiology taping as an adjunct to the BoNT injections in patients with CD. METHODS Twenty-five patients were enrolled to the study. Patients were randomly assigned to the experimental 1 (BoNT + KinesioTaping), experimental 2 (BoNT + ShamTaping) or control (BoNT) treatment. After 12 weeks they were moved to the next experimental group and finally every patient received all 3 proposed treatment options. The severity of CD was quantified with the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) including Torticollis severity, Disability, and Pain scales. Quality of life was evaluated using Craniocervical dystonia questionnaire (CDQ4). RESULTS In all treatment groups, there was a significant improvement in dystonia symptoms measured with TWSTRS (total score) after BoNT injection regardless of the allocation to the experimental treatment (p < .05). ANOVA analysis revealed no differences in any of the TWSTRS variables after the intervention. Quality of life was significantly improved after application of taping (p < .05, p = .03). CONCLUSIONS Application of KinesioTaping after BoNT injection provided no additional effect on the severity of dystonia, although the quality of life was improved in patients with CD. Further research investigating the effect of KinesioTaping prior to BoNT injection is required.
Collapse
Affiliation(s)
- Małgorzata Dec-Ćwiek
- Department of Neurology, Medical College, Jagiellonian University, Krakow, Poland
| | - Karolina Porębska
- Department of Neurology, Medical College, Jagiellonian University, Krakow, Poland
| | - Katarzyna Sawczyńska
- Department of Neurology, Medical College, Jagiellonian University, Krakow, Poland
| | - Marcin Kubala
- Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Krakow University, Krakow, Poland
| | - Magdalena Witkowska
- Department of Neurology, Medical College, Jagiellonian University, Krakow, Poland
| | - Kinga Zmijewska
- Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Krakow University, Krakow, Poland.,Department of Orthopedics and Physiotherapy, Medical College, Jagiellonian University, Krakow, Poland
| | - Jakub Antczak
- Department of Neurology, Medical College, Jagiellonian University, Krakow, Poland
| | - Joanna Pera
- Department of Neurology, Medical College, Jagiellonian University, Krakow, Poland
| |
Collapse
|
6
|
Sawczyńska K, Wężyk K, Bosak M, Jagiełła J, Andrasik S, Kępińska-Wnuk A, Dec-Ćwiek M, Słowik A. Acute-onset chorea and confusional state in 77-year-old COVID-19 patient: a case report. Neurol Neurochir Pol 2022; 56:106-110. [PMID: 34985113 DOI: 10.5603/pjnns.a2022.0003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2021] [Revised: 11/24/2021] [Accepted: 11/24/2021] [Indexed: 11/25/2022]
Affiliation(s)
- Katarzyna Sawczyńska
- Department of Neurology, Jagiellonian University Medical College, Krakow, Poland. .,Department of Neurology, University Hospital in Krakow, Poland.
| | - Kamil Wężyk
- Department of Neurology, University Hospital in Krakow, Poland.,Department of Physiotherapy, Jagiellonian University Medical College, Krakow, Poland
| | - Magdalena Bosak
- Department of Neurology, Jagiellonian University Medical College, Krakow, Poland.,Department of Neurology, University Hospital in Krakow, Poland
| | - Jeremiasz Jagiełła
- Department of Neurology, Jagiellonian University Medical College, Krakow, Poland.,Department of Neurology, University Hospital in Krakow, Poland
| | - Szymon Andrasik
- Department of Neurology, University Hospital in Krakow, Poland
| | - Alicja Kępińska-Wnuk
- Department of Neurology, Jagiellonian University Medical College, Krakow, Poland.,Department of Neurology, University Hospital in Krakow, Poland
| | - Małgorzata Dec-Ćwiek
- Department of Neurology, Jagiellonian University Medical College, Krakow, Poland.,Department of Neurology, University Hospital in Krakow, Poland
| | - Agnieszka Słowik
- Department of Neurology, Jagiellonian University Medical College, Krakow, Poland.,Department of Neurology, University Hospital in Krakow, Poland
| |
Collapse
|
7
|
Dec-Ćwiek M, Porębska K, Witkowska M, Antczak J, Bosak M, Tutaj M. Pure autonomic failure: the first report in Poland? Pol Arch Intern Med 2021; 132. [PMID: 34913328 DOI: 10.20452/pamw.16175] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Affiliation(s)
- Małgorzata Dec-Ćwiek
- Department of Neurology, Jagiellonian University Medical College, Kraków, Poland.
| | - Karolina Porębska
- Department of Neurology, Jagiellonian University Medical College, Kraków, Poland
| | - Magdalena Witkowska
- Department of Neurology, Jagiellonian University Medical College, Kraków, Poland
| | - Jakub Antczak
- Department of Neurology, Jagiellonian University Medical College, Kraków, Poland
| | - Magdalena Bosak
- Department of Neurology, Jagiellonian University Medical College, Kraków, Poland
| | - Marcin Tutaj
- Department of Neurology, Jagiellonian University Medical College, Kraków, Poland
| |
Collapse
|
8
|
Car H, Bogucki A, Bonikowski M, Dec-Ćwiek M, Drużdż A, Koziorowski D, Rudzińska-Bar M, Sarzyńska-Długosz I, Sławek J. Botulinum toxin type-A preparations are not the same medications - basic science (Part 1). Neurol Neurochir Pol 2021; 55:133-140. [PMID: 33797747 DOI: 10.5603/pjnns.a2021.0027] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2021] [Revised: 02/21/2021] [Accepted: 02/22/2021] [Indexed: 11/25/2022]
Abstract
Botulinum neurotoxin type A (BoNT/A) formulations are widely used in clinical practice. Although they share a common mechanism of action resulting in presynaptic block in acetylocholine release, their structure and pharmacological properties demonstrate some similarities and many differences. Bioequivalence has been discussed since the onset of the clinical use of BoNT/A. In this review, we provide an update on the studies and compare the molecular structure, mechanisms of action, diffusion and spread, as well as immunogenicity and dose equivalence of onabotulinumtoxinA, abobotulinumtoxinA and incobotulinumtoxinA.
Collapse
Affiliation(s)
- Halina Car
- Deprtment of Experimental Pharmacology, Medical University of Bialystok, Poland
| | - Andrzej Bogucki
- Department of Extrapyramidal Disorders, Medical University of Łódź, Poland
| | - Marcin Bonikowski
- Neuro Rehabilitation Department, Movement Analysis Lab., Mazovian Neuropsychiatry Center, Limited Liability Company, Zagórze, Poland
| | - Małgorzata Dec-Ćwiek
- Department of Neurology, Collegium Medicum, Jagiellonian University, Kraków, Poland
| | - Artur Drużdż
- Department of Neurology, Municipal Hospital in Poznań, Poland
| | - Dariusz Koziorowski
- Department of Neurology, Faculty of Health Sciences, Medical University of Warsaw, Warszawa, Poland
| | - Monika Rudzińska-Bar
- Department of Neurology, Faculty of Medicine and Health Sciences. Andrzej Frycz Modrzewski Krakow University, Kraków, Poland
| | - Iwona Sarzyńska-Długosz
- Second Department of Neurology, Neurorehabilitation Ward, Institute of Psychiatry and Neurology, Warsaw, Poland
| | | |
Collapse
|
9
|
Grabska N, Rudzińska M, Dec-Ćwiek M, Tutaj M, Pietraszko W, Michalski M, Szczudlik A. Deep brain stimulation in the treatment of Holmes tremor – A long-term case observation. Neurol Neurochir Pol 2014; 48:292-5. [DOI: 10.1016/j.pjnns.2014.06.002] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2014] [Revised: 06/13/2014] [Accepted: 06/17/2014] [Indexed: 10/25/2022]
|